Ng, Juki

Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

Taylor, H. S., Giudice, L. C., Lessey, B. A., Abrao, M. S., Kotarski, J., Archer, D. F., Diamond, M. P., Surrey, E., Johnson, N. P., Watts, N. B., et al. (2017) · New England Journal of Medicine

Endometriosis Research and TreatmentMenstrual Health and Disorders

Cited by 511

Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension Studies

Surrey, E., Taylor, H. S., Giudice, L., Lessey, B. A., Abrao, M. S., Archer, D. F., Diamond, M. P., Johnson, N. P., Watts, N. B., Gallagher, J. C., et al. (2018) · Obstetrics & Gynecology

Endometriosis Research and TreatmentMenstrual Health and Disorders

Cited by 139

Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women

Ng, J., Chwalisz, K., Carter, D. C., & Klein, C. E. (2017) · The Journal of Clinical Endocrinology & Metabolism

Hypothalamic control of reproductive hormonesOvarian function and disorders

Cited by 110

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis

Shebley, M., Polepally, A. R., Nader, A., Ng, J. W., Winzenborg, I., Klein, C. E., Noertersheuser, P., Gibbs, M. A., & Mostafa, N. M. (2020) · Clinical Pharmacokinetics

Endometriosis Research and TreatmentReproductive Health and Contraception

Cited by 68